Drug Profile
DE 098
Alternative Names: Anti-APO-1 monoclonal antibody; ARG-098; DE-098Latest Information Update: 05 Nov 2023
Price :
$50
*
At a glance
- Originator Centocor
- Developer Argenes; AYUMI Pharma
- Class Antirheumatics; Monoclonal antibodies
- Mechanism of Action Apoptosis stimulants; CD95 antigen inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Rheumatoid arthritis
Most Recent Events
- 28 Jul 2015 Discontinued - Phase-I/II for Rheumatoid arthritis in Europe (Intra-articular)
- 28 Jul 2015 Discontinued - Phase-II for Rheumatoid arthritis in Japan (Intra-articular)
- 03 Dec 2010 Phase-II clinical trials in Rheumatoid arthritis in Japan (Intra-articular) (JapicCTI111469)